Reuters logo
2 个月内
BRIEF-Health Canada approves Bristol-Myers' opdivo(nivolumab)
2017年5月17日 / 中午12点26分 / 2 个月内

BRIEF-Health Canada approves Bristol-Myers' opdivo(nivolumab)

1 分钟阅读

May 17 (Reuters) - Bristol-Myers Squibb Co

* Health Canada approves opdivo (nivolumab) for the treatment of squamous cell carcinoma of the head and neck

* Bristol- Myers Squibb Co says data to support approval was based on Checkmate-141, a phase three clinical trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below